• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

March 21, 2018

View Archived Issues

Institut Pasteur de Montevideo and Universidad de la Republica describe new trolox derivatives

Read More

MJFF announces funding for investigator-initiated projects in Parkinson's disease

Read More

Immunicum obtains ATMP certificate from EMA for ilixadencel

Read More

Novel orthoIL-2/IL-2R pairs show efficacy in mouse model of melanoma

Read More

FDA expands approval of Adcetris

Read More

FDA clears Therapix's IND for phase IIa study of THX-110

Read More

Ocugen's phase II study of OCU-310 demonstrates proof-of-concept for dry eye disease

Read More

Antibe Therapeutics' ATB-346 shows better gastrointestinal safety in phase IIb study

Read More

Intranasal octreotide formulation DP-1038 demonstrates viability in healthy volunteers

Read More

KemPharm reports positive topline results from PK study of KP-415

Read More

Curtana Pharmaceuticals describes new Oligo2 inhibitors

Read More

PR-001, a new 5-HT7 inhibitor for the treatment of inflammatory bowel disease

Read More

Novel Bcl-2 inhibitors identified at Centaurus BioPharma

Read More

Zealand reports phase III immunogenicity results for dasiglucagon

Read More

Shanghai Institute Materia Medica discovers bromodomain-containing protein 4 inhibitors

Read More

Biophytis seeks E.U. orphan drug designation for Sarconeos for DMD

Read More

Bristol-Myers Squibb discovers novel indoleamine 2,3-dioxygenase 1 inhibitors

Read More

Idenix Pharmaceuticals, Merck & Co. patent novel tenofovir prodrugs

Read More

Prothena collaborates with Celgene to develop new therapies for neurodegenerative diseases

Read More

Helsinn to acquire worldwide rights to Valchlor/Ledaga

Read More

ON-150030, a novel therapeutic agent to treat acute myeloid leukemia through FLT3 inhibition

Read More

MHRA allows U.K. early access to volanesorsen for familial chylomicronemia syndrome

Read More

Arena reports promising topline results from phase II trial of etrasimod in ulcerative colitis

Read More

Anti-HIV monoclonal antibody VRC07-523LS safe and well-tolerated in phase I study

Read More

First phase II results for GV-1001 in benign prostatic hyperplasia

Read More

FDA approves Ilumya for moderate to severe plaque psoriasis

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe